Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes

NAFLD 2020: The State of the Disease

(2020) Thomas G. Cotter et al.   GASTROENTEROLOGY

Prevalence of Liver Steatosis and Fibrosis Detected by Transient Elastography in Adolescents in the 2017–2018 National Health and Nutrition Examination Survey

(2020) Stefano Ciardullo et al.   Clinical Gastroenterology and Hepatology

Screening strategies for nonalcoholic fatty liver disease in type 2 diabetes: Insights from NHANES 2005–2016

(2020) Stefano Ciardullo et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Comments on: Serum nesfatin-1 and galanin concentrations in the adult with metabolic syndrome. Relationships to insulin resistance and obesity.

(2019) Abdulghani Al Saeed et al.   SAUDI MEDICAL JOURNAL

The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease

(2017) Shujun Zhang et al.   Lipids in Health and Disease

Triglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects

(2017) Shujun Zhang et al.   MEDICINE

Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease

(2017) Chiara Gelli et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Clinical course of nonalcoholic fatty liver disease: an assessment of severity, progression, and outcomes

(2017) Jason Simeone et al.   Clinical Epidemiology

Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort

(2017) Eline H. van den Berg et al.   PLoS One

Triglyceride glucose-waist circumference, a novel and effective predictor of diabetes in first-degree relatives of type 2 diabetes patients: cross-sectional and prospective cohort study

(2016) Shuang Zheng et al.   Journal of Translational Medicine

The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)

(2016) Elena Buzzetti et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Association between Lipid Ratios and Insulin Resistance in a Chinese Population

(2015) Liying Zhang et al.   PLoS One

Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease

(2014) L. Fedchuk et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance

(2014) Tingting Du et al.   Cardiovascular Diabetology

Circulating Levels of Sirtuin 4, a Potential Marker of Oxidative Metabolism, Related to Coronary Artery Disease in Obese Patients Suffering from NAFLD, with Normal or Slightly Increased Liver Enzymes

(2014) Giovanni Tarantino et al.   Oxidative Medicine and Cellular Longevity

Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome

(2014) Hannele Yki-Järvinen   Lancet Diabetes & Endocrinology

Novel therapeutic targets for nonalcoholic fatty liver disease

(2013) Akiko Eguchi et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 Diabetes

(2013) Andreas L. Birkenfeld et al.   HEPATOLOGY

Epidemiological Survey and Risk Factors Analysis of Fatty Liver Disease of Adult Residents, Beijing, China

(2013) Jie Yan et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: Results of a US national survey in three ethnic groups

(2013) Mark M Smits et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

(2013) Quentin M. Anstee et al.   Nature Reviews Gastroenterology & Hepatology

The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

(2012) Naga Chalasani et al.   GASTROENTEROLOGY

Predicting insulin resistance using the triglyceride-to-high-density lipoprotein cholesterol ratio in Taiwanese adults

(2011) Jui-Kun Chiang et al.   Cardiovascular Diabetology

TyG index performs better than HOMA in a Brazilian population: A hyperglycemic clamp validated study

(2011) Ana Carolina Junqueira Vasques et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Human Fatty Liver Disease: Old Questions and New Insights

(2011) J. C. Cohen et al.   SCIENCE

From the metabolic syndrome to NAFLD or vice versa?

(2010) Ester Vanni et al.   DIGESTIVE AND LIVER DISEASE

The Product of Triglycerides and Glucose, a Simple Measure of Insulin Sensitivity. Comparison with the Euglycemic-Hyperinsulinemic Clamp

(2010) Fernando Guerrero-Romero et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Product of Fasting Glucose and Triglycerides As Surrogate for Identifying Insulin Resistance in Apparently Healthy Subjects

(2008) Luis E. Simental-Mendía et al.   Metabolic Syndrome and Related Disorders